Brandes Investment Partners LP Acquires 13,392 Shares of Utah Medical Products, Inc. $UTMD

Brandes Investment Partners LP grew its holdings in Utah Medical Products, Inc. (NASDAQ:UTMD) by 4.0% in the 4th quarter, HoldingsChannel reports. The firm owned 351,322 shares of the medical instruments supplier’s stock after buying an additional 13,392 shares during the quarter. Brandes Investment Partners LP owned about 0.11% of Utah Medical Products worth $19,660,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. O Shaughnessy Asset Management LLC raised its holdings in shares of Utah Medical Products by 2.3% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 14,903 shares of the medical instruments supplier’s stock valued at $834,000 after purchasing an additional 337 shares in the last quarter. Comerica Bank raised its stake in shares of Utah Medical Products by 435.6% during the 3rd quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 440 shares in the last quarter. Cardinal Capital Management raised its stake in shares of Utah Medical Products by 1.9% during the 4th quarter. Cardinal Capital Management now owns 24,836 shares of the medical instruments supplier’s stock worth $1,394,000 after acquiring an additional 459 shares in the last quarter. Ritholtz Wealth Management raised its stake in shares of Utah Medical Products by 9.4% during the 4th quarter. Ritholtz Wealth Management now owns 5,514 shares of the medical instruments supplier’s stock worth $309,000 after acquiring an additional 472 shares in the last quarter. Finally, State of Wyoming raised its stake in shares of Utah Medical Products by 20.4% during the 4th quarter. State of Wyoming now owns 2,810 shares of the medical instruments supplier’s stock worth $157,000 after acquiring an additional 476 shares in the last quarter. Institutional investors own 69.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “hold (c-)” rating on shares of Utah Medical Products in a research note on Friday, May 22nd. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, Utah Medical Products has a consensus rating of “Hold”.

Utah Medical Products Trading Up 0.8%

Shares of Utah Medical Products stock opened at $68.60 on Thursday. Utah Medical Products, Inc. has a 12-month low of $52.00 and a 12-month high of $71.81. The firm has a market capitalization of $218.15 million, a price-to-earnings ratio of 20.30 and a beta of 0.37. The firm’s 50 day simple moving average is $65.84 and its two-hundred day simple moving average is $62.60.

Utah Medical Products (NASDAQ:UTMD) last issued its quarterly earnings results on Thursday, April 23rd. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 28.90% and a return on equity of 9.13%. The business had revenue of $8.72 million for the quarter.

Utah Medical Products Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 3rd. Shareholders of record on Wednesday, June 17th will be paid a dividend of $0.31 per share. The ex-dividend date is Wednesday, June 17th. This represents a $1.24 dividend on an annualized basis and a yield of 1.8%. Utah Medical Products’s dividend payout ratio is presently 36.69%.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).